Research Topics
| Matthew R ReynoldsSummaryAffiliation: Harvard University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugsMatthew R Reynolds
Beth Israel Deaconess Medical Center, Harvard Clinical Research Institute, Boston, Mass, USA
Circ Cardiovasc Qual Outcomes 3:615-23. 2010..In patients with paroxysmal atrial fibrillation (AF), catheter ablation maintains sinus rhythm more effectively than antiarrhythmic drugs (AADs), but its effect on symptoms and quality of life (QOL) has not been fully characterized...
Quality of life in atrial fibrillation: measurement tools and impact of interventionsMatthew R Reynolds
Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
J Cardiovasc Electrophysiol 19:762-8. 2008..This paper will review the rationale, design, strengths, and limitations of the questionnaires most commonly used to assess QoL in AF studies, and present QoL outcomes from major studies of AF interventions...
Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registryMatthew R Reynolds
Beth Israel Deaconess Medical Center, Division of Cardiology, Boston, MA 02215, USA
J Cardiovasc Electrophysiol 18:628-33. 2007..We sought to characterize the resource utilization and costs of treating new-onset AF, with emphasis on the incremental costs associated with recurrent episodes of AF over time...
The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillatorsMatthew R Reynolds
Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
J Am Coll Cardiol 47:2493-7. 2006..We aimed to quantify the frequency and nature of early complications after implantable cardioverter-defibrillator (ICD) implantation in general practice, and estimate the incremental costs of those complications to the health care system...
Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillationMatthew R Reynolds
Beth Israel Deaconess Medical Center, Boston, Mass 02215, USA
Circ Arrhythm Electrophysiol 2:362-9. 2009..The potential cost-effectiveness of RFA for AF, relative to antiarrhythmic drug (AAD) therapy, has not been fully explored from a US perspective...
Relationship of baseline electrocardiographic characteristics with the response to cardiac resynchronization therapy for heart failureMatthew R Reynolds
Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
Pacing Clin Electrophysiol 27:1513-8. 2004..ECG markers of anterior infarction and RV dilation may help identify CHF patients unlikely to benefit from biventricular pacing. Further assessment is needed of these and other predictors of therapeutic response to CRT...
Impact of hospitalization on health-related quality of life in atrial fibrillation patients in Canada and the United States: results from an observational registryMatthew R Reynolds
Beth Israel Deaconess Medical Center, Harvard Clinical Research Institute, Boston, MA 02215, USA
Am Heart J 160:752-8. 2010..Hospitalization is recognized as an important end point in atrial fibrillation (AF). The association between hospitalization and reduced health-related quality of life (HRQOL) has not been previously studied...
Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) studyMatthew R Reynolds
Division of Cardiology, Beth Israel Deaconess Medical Center, 185 Pilgrim Road Baker 4, Boston, MA 02215, USA
Am Heart J 152:1097-103. 2006..We sought to characterize symptoms and QoL in a large inception cohort of unselected patients with AF and explore the impact of age, sex, and AF clinical course on QoL measures over time...
Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablationJoseph A Ladapo
Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
J Cardiovasc Electrophysiol 23:1-8. 2012..The aim was to estimate the impact of catheter ablation on short- and long-term healthcare utilization and expenditures among atrial fibrillation (AF) patients in general and Medicare populations...
Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costsPeter Zimetbaum
Division of Cardiology, Beth Israel Deaconess Medical Center, One Deaconess Road, Boston, MA 02215, USA
Am J Cardiol 92:677-81. 2003..We conclude that the implementation of our practice guideline was feasible, safe, and effective. Widespread adoption of such practices may have large financial implications for the health care system...
Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A)Matthew R Reynolds
Harvard Clinical Research Institute, Boston, Massachusetts, USA
J Am Coll Cardiol 60:2683-92. 2012..The aim of this study was to evaluate the cost-effectiveness of transcatheter aortic valve replacement (TAVR) compared with surgical aortic valve replacement (AVR) for patients with severe aortic stenosis and high surgical risk...
Bi-directional electrical pulmonary vein isolation as an endpoint for ablation of paroxysmal atrial fibrillationVidal Essebag
Harvard-Thorndike Electrophysiology Institute Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, MA, USA
J Interv Card Electrophysiol 17:111-7. 2006..Avoidance of routine additional left atrial ablation lines may decrease the risk of atrial tachycardia and esophageal fistula...
Cost-effectiveness of sirolimus-eluting stents compared with vascular brachytherapy for the treatment of in-stent restenosisMatthew R Reynolds
Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, USA
Am Heart J 154:1221-7. 2007..Sirolimus-eluting stents (SESs) were recently shown to be superior to vascular brachytherapy for the treatment of restenosis within a bare metal stent. No economic comparison of these alternative strategies has yet been reported...
Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL RegistryMatthew R Reynolds
Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
Am J Cardiol 97:538-43. 2006..The discontinuation of warfarin in a large number of patients with AF over time is a cause for concern in light of data from recent clinical trials...
Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation: results of a propensity-matched analysisMatthew R Reynolds
Department of Cardiology, Beth Israel Deaconess Medical Center and the VA Boston Healthcare System, Boston, MA, USA
Circ Cardiovasc Qual Outcomes 5:171-81. 2012..The objective of this study was to determine whether AF ablation reduces the long-term risk of stroke or heart failure compared with antiarrhythmic drug therapy...
Non-inducibility post-pulmonary vein isolation achieving exit block predicts freedom from atrial fibrillationVidal Essebag
Harvard-Thorndike Electrophysiology Institute, Cardiovascular Division, Beth Israel Deaconess Medical Center, 185 Pilgrim Road, Baker 4, Boston, MA 02215, USA
Eur Heart J 26:2550-5. 2005..012) predicted freedom from AF at 12 months. CONCLUSION: Non-inducibility of AF after bi-directional PV isolation predicts maintenance of sinus rhythm. This finding suggests that routine extensive left atrial ablation may be unnecessary...
Inducibility of atrial fibrillation with a synchronized external low energy shock post-pulmonary vein isolation predicts recurrent atrial fibrillationJohn V Wylie
Harvard Thorndike Electrophysiology Institute, Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
J Cardiovasc Electrophysiol 20:29-36. 2009..Inducibility of atrial fibrillation (AF) with burst pacing after pulmonary vein (PV) isolation is associated with recurrent AF...
Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experienceMatthew R Reynolds
Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
Am Heart J 145:334-42. 2003..Despite a higher rate of repeat revascularization, multivessel stenting was significantly less costly than CABG through the first 2 years of follow-up...
Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiariesEthan R Ellis
Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
Heart Rhythm 6:1267-73. 2009..Utilization of radiofrequency catheter ablation (RFA) for treatment of atrial fibrillation (AF) is increasing. Data regarding the safety of RFA for AF outside of selected centers of excellence and in older patients are limited...
Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromesDuane S Pinto
Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02115, USA
J Am Coll Cardiol 52:1758-68. 2008..The aim of this study was to determine the economic impact of several anticoagulation strategies for moderate- and high-risk non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients managed invasively...
Prophylactic catheter ablation for the prevention of defibrillator therapyVivek Y Reddy
Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, USA
N Engl J Med 357:2657-65. 2007..We designed this randomized trial to examine whether prophylactic radiofrequency catheter ablation of arrhythmogenic ventricular tissue would reduce the incidence of ICD therapy...
A cost-minimization analysis of the angio-seal vascular closure device following percutaneous coronary interventionFrederic S Resnic
Cardiovascular Division, Department of Radiology, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Am J Cardiol 99:766-70. 2007..This cost savings was in addition to the previously demonstrated advantages of Angio-Seal in terms of patient comfort and preference...
MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policyMatthew R Reynolds
Beth Israel Deaconess Medical Center, Boston, Mass 02215, USA
Circulation 108:1779-83. 2003
Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A)Matthew R Reynolds
Harvard Clinical Research Institute, Boston VA Healthcare System, Boston, Massachusetts, USA
J Am Coll Cardiol 60:548-58. 2012....
Current clinical characteristics and economic impact of subacute stent thrombosisMatthew R Reynolds
Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
J Invasive Cardiol 14:364-8. 2002..Conclusions. Despite its low overall frequency, the clinical and economic costs of SAT are substantial. Specific strategies at preventing its occurrence are warranted, particularly in high-risk situations...
Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator RegistryAdam S Fein
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
J Am Coll Cardiol 56:766-73. 2010..The purpose of the study was to define the extent and nature of cardiac resynchronization therapy (CRT) device usage outside consensus guidelines using national data...
Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillatorsDaniel B Kramer
Beth Israel Deaconess Medical Center, Boston, Massachusetts 02446, USA
Heart Rhythm 9:42-6. 2012..Better methods are needed for identifying patients at high risk for early mortality despite ICD therapy...
Security and privacy qualities of medical devices: an analysis of FDA postmarket surveillanceDaniel B Kramer
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
PLoS ONE 7:e40200. 2012..These computing capabilities introduce security and privacy risks, yet little is known about the prevalence of such risks within the clinical setting...
Mortality following defibrillator implantation in patients with renal insufficiencyRobert E Eckart
Brigham and Women s Hospital, and Harvard Medical School, Boston, Massachusetts, USA
J Cardiovasc Electrophysiol 17:940-3. 2006..Due to under-representation of patients with renal disease in large clinical trials, outcomes of implantable cardioverter defibrillator (ICD) implantation in this group remain unclear...
Atrial fibrillation: epidemiology, prognosis and therapyH Rutzen-Lopez
Beth Israel Deaconess Medical Center, VA Boston Healthcare System, Boston, MA, USA
Minerva Med 102:187-207. 2011....
Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillationVidal Essebag
Division of Cardiology, McGill University Health Center, Montreal, Quebec, Canada
Arch Intern Med 167:1648-53. 2007..The aims of this study were to determine prospectively whether amiodarone increases the need for pacemakers in a general population of patients with AF and whether this effect is modified by sex...
Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's diseasePeleg M Horowitz
Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA
J Neurosci 24:7895-902. 2004..Collectively, these results suggest a role for caspase-6 and N-terminal truncation of tau during neurofibrillary tangle evolution and the progression of Alzheimer's disease...
The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare programPhillip P Brown
Cardiac Data Solutions, Inc, Atlanta, Georgia, USA
Ann Thorac Surg 85:1980-6. 2008..We estimate the incremental hospital resource consumption associated with treating selected complications experienced by Medicare beneficiaries undergoing coronary artery bypass grafting (CABG)...
Ossified pseudomeningocele following Chiari decompression surgery in a patient with Kleeblattschädel deformityMatthew R Reynolds
Department of Neurosurgery, Washington University, St Louis Children s Hospital, St Louis, MO 63110, USA
J Neurosurg Pediatr 2:203-6. 2008..A genetic basis for the ossification process seems likely given the child's history of premature cranial suture closure. The authors draw attention to this rare complication and review the available body of literature on this topic...
Research Grants
- Tau Nitration in Alzheimer's PathogenesisMatthew Reynolds; Fiscal Year: 2007..In this proposal, we will characterize the specific sites of T nitration in vitro and in situ, and determine the effects of nitration on T folding and function. ..
- Cost Effectiveness of Catheter Ablation for Atrial Fibrillation (AF)Matthew Reynolds; Fiscal Year: 2007..Once all of this data is collected, the necessary inputs will combined in a Markov model comparing AF ablation with antiarrhythmic drug therapy, and atrio-ventricular junctional ablation with pacemaker implantation. ..
